6Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors [J]. J Neurogastroenterol Motil,2013, 19(1 ) :25-35.
7Hagymtsi K, Mtillner K, Hersz6nyi L, et al. Update on the pharmacogenomics of proton pump inhibitors [J]. Pharmacogenomics, 2011,12(6) : 873-888.
8Wi lliams MP , S ercombe J , Hamih on M I, et al.A placebo cont roll ed t ri al t o as sess the eft ect s of 8 days of dosing with rabep razole versus om eprazole on 24-h int ragast ri c acidity and plasma gas t rin concen trati ons in young heal thy male sub jects .Aliment Ph armacol T her, 1998,12:1079-1089 .
9Ishiz aki T, H oral Y.Revi ew art icl e:cyt och rome P450 and the metabolism of prot on pure p inhibit orsemph asi s on tab eprazole .Aliment Ph armacol T her, 1999, 13 (su ppl 3):27-36.
10Bes ancon M , Sire on A , Sachs G , et al.Sit es of react ion of the gastric H-K-ATPase with ext racyt oplasmic thiol reagent s .J Biol C hem, 1997,272:22438-224d6 .
